Combined Immune Therapy Examined for Early Type 1 Diabetes
Summary
Two case reports and several ongoing clinical trials highlight the potential of combination immune-modulating therapies to preserve beta-cell function in T1D.
Description from Medscape.
Who is covering this
-
Combined Immune Therapy Examined for Early Type 1 Diabetes
Two case reports and several ongoing clinical trials highlight the potential of combination immune-modulating therapies to preserve beta-cell function in T1D.
Comments
Comments need JavaScript.